High-tech

Internet of things-related innovation among pharma companies dropped off in 2021

Research and innovation in internet of things in the pharmaceutical sector has declined in the last year.

The most recent figures show that the number of IoT patent applications in the industry stood at 54 in the three months ending December – down from 134 over the same period in 2020.

Figures for patent grants related to IoT followed a similar pattern to filings – shrinking from 128 in the three months ending December 2020 to 32 in 2021.

Free whitepaper


IoT: Patent trends 2021

by

Enter your details to receive the free paper:

Thank you.
Please check your email to download the white paper.


The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.

IoT is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

The figures also provide an insight into the largest innovators in the sector.

Johnson & Johnson was the top IoT innovator in the pharmaceutical sector in the last quarter. The company, which has its headquarters in the United States, filed 36 IoT related patents in the three months ending December 2021. That was down from 129 over the same period in 2020.

It was followed by the Germany based Bayer AG with 18 IoT patent applications, Switzerland based F. Hoffmann-La Roche Ltd (12 applications), and the United States based Insulet Corp (8 applications).

Bayer AG has recently ramped up R&D in IoT. It saw growth of 55.6% in related patent applications in the three months ending December compared to the same period last year – the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the pharmaceutical sector.

Related Companies

About the author

MAGASIR

Leave a Comment